Fatty pancreas, insulin resistance, and β-cell function: a population study using fat-water magnetic resonance imaging

VWS Wong, GLH Wong, DKW Yeung… - Official journal of the …, 2014 - journals.lww.com
OBJECTIVES: Nonalcoholic fatty liver disease is the most common chronic liver disease.
Fatty pancreas has also been described but is difficult to assess. It is now possible to …

Enigmatic ectopic fat: prevalence of nonalcoholic fatty pancreas disease and its associated factors in ac hinese population

CY Wang, HY Ou, MF Chen, TC Chang… - Journal of the …, 2014 - Am Heart Assoc
Background Fatty infiltration of the pancreas is an enigmatic manifestation of ectopic fat
deposition in obesity. Studies have shown that pancreatic lipid accumulation interferes with …

Nonalcoholic fatty pancreatic disease and cardio-metabolic risk: is there is a place for obstructive sleep apnea?

AE Mirrakhimov - Cardiovascular Diabetology, 2014 - Springer
Background Obstructive sleep apnea is a common disorder acting as a risk factor for the
development and progression of cardiometabolic derangements including non-alcoholic …

Current options for the diagnosis of chronic pancreatitis

KCP Sze, RC Pirola, MV Apte… - Expert review of molecular …, 2014 - Taylor & Francis
The diagnostic options for chronic pancreatitis have evolved over recent years. The previous
gold standard references for structural imaging and exocrine pancreatic function testing …

Стеатоз печени и стеатоз поджелудочной железы-две мишени метаболического синдрома у детей

ЕИ Алешина, ВП Новикова, ВА Гурьева… - Экспериментальная …, 2014 - cyberleninka.ru
Целью исследования явилось оценка частоты стеатоза печени и стеатоза
поджелудочной железы у детей с ожирением и выявление их взаимосвязи. Материалы …

Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients

J Yao, Y Zhao, J Zhang, Y Hong, H Lu, J Wu - Lipids in health and disease, 2014 - Springer
Background Low serum amylase levels have been reported in patients with metabolic
syndrome (MS), diabetes, and asymptomatic non-alcoholic fatty liver disease (NAFLD) …